Author:
Bahareh Feyzi-barnaji ,Barin Sanaz Meghrazi,Mohammadi Ali,Naeemy Ali,Darbasizadeh Behzad
Reference53 articles.
1. Mehta, S.R., Yusuf, S., Peters, R.J., Bertrand, M.E., Lewis, B.S., Natarajan, M.K., Malmberg, K., Rupprecht, H.J., Zhao, F., and Chrolavicius, S., Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study, Lancet, 2001, vol. 358, p. 527.
2. Frishman, W.H., Cheng-Lai, A., and Nawarskas, J., Current Cardiovascular Drugs, London: Current Medicine Group, 2005.
3. Huynh, K., Clopidogrel is a favourable alternative to ticagrelor in older patients with NSTE-ACS, Nat. Rev. Cardiol., 2020, vol. 17, p. 384.
4. Savi, P., Pereillo, J., Uzabiaga, M., Combalbert, J., Picard, C., Maffrand, J., Pascal, M., and Herbert, J., Identification and biological activity of the active metabolite of clopidogrel, Thromb. Haemost., 2000, vol. 84, p. 891.
5. Xu, L., Hou, Y., Zhang, M., Yang, X., Jenkins, G., Huang, W., Yao, C., and Wu, Q., A novel electrochemical biosensor for detection of cholesterol, Russ. J. Electrochem., 2016, vol. 52, p. 239.